Fixed-Dose Combination Therapy in Hypertension: Pros

By Taddei Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 19, Iss. 2, 2012-06 ,pp. : 55-57

Adis International

Access to resources Recommend Favorite

Fixed-Dose Combination Therapy in Hypertension: Cons

By Angeli Fabio  

High Blood Pressure & Cardiovascular Prevention, Vol. 19, Iss. 2, 2012-06 ,pp. : 51-54

Adis International

Access to resources Recommend Favorite

Three-Year Safety and Effectiveness of Fixed-Dose Losartan/Hydrochlorothiazide Combination Therapy in Japanese Patients with Hypertension Under Clinical Setting (PALM-1 Extension Study)

By Kita Toshihiro   Yokota Naoto   Ichiki Yoshinari   Ayabe Takao   Etoh Takuma   Tamaki Noboru   Kato Johji   Eto Tanenao   Kitamura Kazuo  

Clinical and Experimental Hypertension, Vol. 34, Iss. 7, 2012-11 ,pp. : 498-503

Informa Healthcare

Access to resources Recommend Favorite

The Role of Fixed-Dose Combination Therapy with Drugs that Target the Renin-Angiotensin System in the Hypertension Paradigm

By Schmieder Roland E.  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 35-42

Informa Healthcare

Access to resources Recommend Favorite

Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats

By Sacco Giuseppe   Evangelista Stefano   Manzini Stefano   Parlani Massimo   Bigioni Mario  

Future Cardiology, Vol. 7, Iss. 6, 2011-11 ,pp. : 757-763

Future Medicine

Access to resources Recommend Favorite